Article Details

Quantum BioPharma Completes Phase 1 Trial Of Lucid-21-302 For Multiple Sclerosis Treatment

Retrieved on: 2025-02-26 18:05:57

Tags for this article:

Click the tags to see associated articles and topics

Quantum BioPharma Completes Phase 1 Trial Of Lucid-21-302 For Multiple Sclerosis Treatment. View article details on hiswai:

Excerpt

Quantum BioPharma Ltd. (QNTM) announced the completion of its Phase 1 clinical trial for Lucid-21-302 or Lucid-MS, an experimental drug designed ...

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo